GILD Johanna Mercier sells $3.5M worth of shares
Nov 19, 2025, 5:32 AM
0.00%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
Johanna Mercier sold 28,000 shares of GILD on 17 November at $126.26 per share, worth a total of $3.5M. They now own 109,669 GILD shares, or a 21% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.